Driven by a vision to improve patient outcomes along with pressure to speed time to market, manage costs and navigate regulatory demands, life sciences companies have an urgent need to innovate. How can we help you?
The potential of GenAI in drug discovery and clinical trials
The wait for a new therapy to come to market can be a long one. That’s now changing as Generative AI starts to revolutionize the world of pharmaceutical R&D.
Digital Transformation Solutions in Life Sciences through Manufacturing 4.0
IT-OT convergence in biopharma manufacturing
IT-OT convergence, advanced data analytics and AI technologies are giving biopharma manufacturers the insights to launch and make GMP compliant medicine at an accelerated pace.
Some pharmaceutical companies already have digital twins in production, while others are aiming to meet a 2030 deadline. Still others are probing the possibilities. What can you learn from pioneers?
Harmonizing next-gen MES for smarter manufacturing
MES has evolved to better meet business requirements, driving the reconciliation of quality and speed to market, improving sustainability, minimizing capital spend and enabling the adoption of lean manufacturing principles.
Our latest research with CIONET reveals 6 key findings that will help organizations unleash untapped potential within their analytics and drive successful transformation.
To develop new treatments quickly and cost effectively, life sciences firms need a better way to share vital data, both inside and outside the organization.
Every step of the biopharmaceutical process generates data. Capturing and centralizing that data can help the industry create and deliver medicines and treatments more quickly and efficiently.
While businesses are certainly accustomed to providing digitally accessible experiences to their employees and end users, their focus is often on satisfying the minimum regulatory requirements.
How can we help you?
Let’s talk about how digital can work for your business.